An Enormous Benign Mucinous Ovarian Cystadenoma: A Case Study and Literature Review

Download Article

DOI: 10.21522/TIJPH.2013.12.03.Art061

Authors : Anusha Madasu, Preethi B, Tejaswini, Logeswari BM

Abstract:

An ovarian tumor is not a singular entity, but rather a very wide spectrum of neoplasms spanning a variety of histological tissues [1]. The most common type of tumors, epithelial tumors, account for 80% of all malignancies.10% of tumors are classified as possibly malignant, 8%–10% are malignant, and 80% are benign. About 8–10% of epithelial tumors are mucinous tumors, which can grow to huge sizes and cover the whole abdominal cavity [2], [3]. We would like to share a case study of a 50-year-old female patient who had a large benign mucinous cystadenoma. The patient was unable to receive medical care and had a tumor that was causing her to have trouble breathing. The tumor reacted amazingly well after surgical resection [4]. After the operation, the patient could resume her regular life.

References:

[1].   Eble, J. N., Tavassoli, F. A., Devilee, P., 2003, International Agency for Research on Cancer, World Health Organization. Pathology and genetics of tumours of the breast and female genital organs: Tumours of the breast and female genital organs. Iarc.

[2].   Sonntag, B., Lellé, R. J., Steinhard, J., Brinkmann, O. A., Hungermann, D., & Kiesel, L., 2005, Retroperitoneal mucinous adenocarcinoma occuring during pregnancy in a supernumerary ovary. Journal of Obstetrics and Gynaecology, 25(5), 515–516. https://doi.org/10.1080/01443610500193478.

[3].   Tait, D. L., Miller, D. S., 1997, Multicystic ovarian tumour weighing 156 pounds second largest in texas. Tex Med 93:89.

[4].   Sagiv, Ron M. D., Golan, Abraham M. D., FRCOG; Glezerman, Marek M. D., 2005, Laparoscopic Management of Extremely Large Ovarian Cysts. Obstetrics & Gynecology 105(6):p 1319-1322, DOI: 10.1097/01.AOG.0000159690.18634.f0.

[5].   Tjalma W. A. A., Vaneerdeweg, W., 2008, Primary retroperitoneal mucinous cystadenocarcinomas are a distinct entity, Int. J. Gynecol. Cancer, vol. 18, no. 1, p. 184, doi: 10.1136/ijgc-00009577-200801000-00032.

[6].   An, J. Y., Heo, J. S., Noh, J. H., Sohn, T. S., Nam, S. J., Choi, S. H., Joh, J. W., Kim, S. J., 2007, Primary malignant retroperitoneal tumors: Analysis of a single institutional experience. European Journal of Surgical Oncology (EJSO), 33(3), 376-82.

[7].   Crum, C. P., Lester, S. C., Cotran, R. S., 2007, Pathology of female genital system and breast. In: by Kumar, V., Abbas, A., Fausto, N., Mitchell, R., eds. Robbins’ Basic Pathology. 8th ed. USA: Elsevier Company, Chapt. 19.

[8].   de León, D. C., Pérez-Montiel, D., Chanona-Vilchis, J., Dueñas-González, A., 2007, Villavicencio-Valencia, V., Zavala-Casas, G., Primary retroperitoneal mucinous cystadenocarcinoma: Report of two cases, World Journal of Surgical Oncology, 5, 1-6.

[9].   Buy, J. N., Ghossain, M. A., Sciot, C., Bazot, M., Guinet, C., Prévot, S., Hugol, D., Laromiguiere, M., Truc, J.B., Poitout, P., 1991, Epithelial tumors of the ovary: CT findings and correlation with US. Radiology, 178(3), 811-8.

[10].  Poli Neto, O. B., Candido Dos Reis, F. J., Zambelli Ramalho, L. N., Nogueira, A. A., de Andrade, J. M., 2006, p63 expression in epithelial ovarian tumors. Int J Gynecol Cancer, 16(1), 152-5.

[11].  McCluggage, W. G., 2011, Morphological subtypes of ovarian carcinoma: A review with emphasis on new developments and pathogenesis, Pathology, 43, 420–432.

[12].  Baksu, B., Akyol, A., Davas, I., Yazgan, A., Ozgul, J., Tanık, C., 2006, Recurrent mucinous cystadenoma in a 20-year-old woman: Was hysterectomy inevitable? Journal of Obstetrics and Gynaecology Research, 32, 615-618, https://doi.org/10.1111/j.1447-0756.2006.00453.x.

[13].  Kokawa, K., Mikami, Y., Sakata, H., Oki, N., Tanakas, T., Yamazaki, M., Nakata Y, Umesaki, N., 2009, Clinical outcome and prognostic factors in borderline tumors of the ovary. Results from 17 years’ experience in the Kinki District of Japan (1990-2006). Eur. J. Gynaec. Oncol.-ISSN, 392, 2936.

[14].  De Iaco, P., Ferrero, A., Rosati, F., et al., 2009, Behaviour of ovarian tumors of low malignant potential treated with conservative surgery, Eur J Surg Oncol, 35, 643–648.

[15].  Katke, R. D., 2014, International Journal of Reproduction, Contraception, Obstetrics and Gynecology, Vol. 2, 459.

[16].  Seidman, J. D., Mehrotra, A., 2005, Benign ovarian serous tumors: A re-evaluation and proposed reclassification of serous ‘cystadenomas’ and ‘cystadenofibromas’. Gynecol Oncol. 96(2), 395-401.

[17].  Cuatrecasas, M., Villanueva, A., Matias-Guiu, X., Prat, J., 1997, K-ras mutations in mucinous ovarian tumors: A clinicopathologic and molecular study of 95 cases. Cancer, 79(8), 1581-6.

[18].  Lalwani, N., Shanbhogue, A. K. P., Vikram, R., Nagar, A., Jagirdar, J., Prasad, S. R., 2010, Current update on borderline ovarian neoplasms, AJR Am J Roentgenol, 194, 330–336.

[19].  Howard, W., Epithelial ovarian cancer. In: Jones, Anne Colston Wentz, Lonnie S. Burnett, eds. Novak’s Textbook of Gynaecology. 11th ed. UK, 1, Williams & Wilkins 988: 806-809.

[20].  Wilfred Shaw, John Howkins, Gordon Lionel Bourne. Disorders of the ovary and benign tumours. In: Wilfred Shaw, John Howkins, Gordon Lionel Bourne, eds. Shaw’s Textbook, 14th ed. London: Churchill Livingstone; 2008: 334.